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Natural killer (NK) cells are considered to play a critical role in liver disease. However, the
available numbers of intrahepatic lymphocytes (IHL) derived from liver biopsies (LB) for ex
vivo analysis of intrahepatic NK cells is very limited; and the isolation method may hamper
not only yields and viability, but also phenotype and function of IHL.The aim of the present
study was therefore to (1) refine and evaluate the cell yields and viability of a modified
isolation protocol from standard size needle LB; and (2) to test the effects of mechanical
dissociation and enzymatic tissue digestion, as well as the analysis of very low cell num-
bers, on the phenotype and function of intrahepatic NK cells. Peripheral blood mononuclear
cells (PBMC) and IHL, freshly isolated from the peripheral blood, LB (n=11) or partial liver
resections (n=5), were used for phenotypic analysis by flow cytometry. NK cell function,
i.e., degranulation and cytokine production, was determined by staining of CD107a and
intracellular IFN-γ following in vitro stimulation. The mean weight of the LB specimens
was 9.1 mg, and a mean number of 7,364 IHL/mg were obtained with a viability of >90%.
Exposure of IHL and PBMC to 0.5 mg/ml collagenase IV and 0.02 mg/ml DNase I for 30 min
did affect neither the viability, NK cell function, nor the percentages of CD56+, NKp46+,
and CD16+ NK cells, whereas the level of CD56 surface expression was reduced.The phe-
notype of LB-derived NK cells was reliably characterized by acquiring as few as 2,500 IHL
per tube for flow cytometry.The functional assay of intrahepatic NK cells was miniaturized
by culturing as few as 25,000 IHL in 25 6µl (10 /ml) using 96-well V-bottom plates with IL-2
and IL-12 overnight, followed by a 4 h stimulation with K562 cells at a NK:K562 ratio of 1:1.
In summary, we report reliable phenotypic and functional analyses of small numbers of
intrahepatic NK cells isolated from LB specimens providing us with a tool to better address
the emerging role of human NK cell immunobiology in liver diseases.
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INTRODUCTION
The liver is a unique immunological site, constantly exposed to
gut-derived bacterial products, environmental toxins, and food
antigens (Crispe, 2009). The presence of a strong innate immune
system provides rapid and efficient resistance against potential
pathogens and toxic compounds, while tolerance mechanisms pre-
vent harmful responses against food antigens and auto-immunity
(Doherty and O’Farrelly, 2000; Gao et al., 2008). Beside the cells
implicated in adaptive immunity, such as T lymphocytes and den-
dritic cells, several innate immune cells, such as natural killer (NK),
NKT,γδT cells, and Kupffer cells, are present in the liver (Gao et al.,
2008; Yamagiwa et al., 2009).
Intrahepatic NK cells are preferentially located in the distinc-
tive, thin-walled sinusoids, whereas Kupffer cells and resident
lymphocytes are mostly found in the parenchyma (Doherty and
Abbreviations: IHL, intrahepatic lymphocytes; LB, liver biopsy; MFIR, mean fluo-
rescence intensity ratio; NK, natural killer; PBMC, peripheral blood mononuclear
cells.
O’Farrelly, 2000; Crispe, 2009). In humans, the repertoire of
intrahepatic lymphocytes (IHL) differs from peripheral blood
lymphocytes with NK cells comprising approximately 30–50%
(of IHL) (Norris et al., 1998; Doherty and O’Farrelly, 2000; Tian
et al., 2012), a much higher percentage than in the peripheral
blood (5–15% of peripheral blood lymphocytes) (Lanier et al.,
1986). Emerging data from observational human and experimen-
tal animal studies have revealed that the liver microenvironment
modifies the activating/inhibitory NK cell receptor expression and
the functional responsiveness of NK cells recruited to the liver.
These modifications depend on both the secretion of cytokines and
cell-to-cell interactions, such as the crosstalk between NK cells and
liver-resident dendritic (Jinushi et al., 2007) and stellate cells (Hin-
termann et al., 2010). Thus, NK cells play a central role not only in
innate immunity, but also in shaping adaptive immune response
in the liver (Krueger et al., 2011). Taken together, intrahepatic NK
cells seem to exhibit unique phenotypic and functional properties
in health and disease (Norris et al., 1998; Ishiyama et al., 2006;
Bonorino et al., 2009; Mondelli et al., 2010; Zhang et al., 2011)
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and have therefore become an object of great scientific interest, in
particular with respect to their role in controlling viral hepatitis,
liver fibrosis, and liver tumorigenesis but also in contributing to
the pathogenesis of liver injury and persistent inflammation (Nair
et al., 2010; Shi et al., 2011; Tian et al., 2012).
The great interest in intrahepatic NK cells is reflected by the
multitude of recent reports on their phenotype (Nattermann et al.,
2005, 2006; Dunn et al., 2007; Yamagiwa et al., 2008; Ahlenstiel
et al., 2010; Mondelli et al., 2010). So far, the source for these
studies has mainly been liver resection specimens thus limiting
the spectrum of patients accessible to analysis to those under-
going surgery. On the other hand, liver biopsies (LB) are the
diagnostic “gold standard” for many liver pathologies, visualiz-
ing the necro-inflammatory and architectural status of the liver by
immunohistology, with the advantage of precise in situ localiza-
tion of IHL (Bravo et al., 2001; Cholongitas et al., 2006; Lefkowitch,
2007; Nair et al., 2010). Nevertheless, while much more practical
and less invasive than liver resections, percutaneous or transjugu-
lar needle LB have a number of limitations for research purposes.
First, some antibodies used for cell staining are only applicable
by flow cytometry, but not by immunohistochemistry; second, it
is demanding to stain for multiple immunohistological markers
necessary for the identification of specific IHL cell subsets. Third,
the small size of LB limits the number of IHL that can be iso-
lated, and the mechanical and enzymatic isolation methods may
hamper their viability, the cell yields and cell-surface expression of
certain lymphocyte markers (Mulder et al., 1994; Ishiyama et al.,
2006; Mondelli et al., 2010). Consequently, using LB specimens
for detailed phenotypical analyses of IHL, and in particular for
functional studies requiring in vitro culturing has been a challeng-
ing endeavor. For all these technical reasons the vast majority of
functional studies of NK cell in liver diseases have focused on cir-
culating peripheral blood NK cells rather than on intrahepatic NK
cells. However, the results obtained with circulating NK cells do
not necessarily predict the cytotoxicity or cytokine production of
intrahepatic NK cells.
The aim of the present study was (1) to refine and evaluate a
modified protocol to isolate IHL from standard size needle LB sam-
ples with respect to cell yields and viability,and (2) to test the effects
of the isolation protocol and the analysis of very low cell numbers
on phenotype and function of intrahepatic NK cells. To this end,
intrahepatic NK cells isolated from LB and partial liver resection
specimens were analyzed in comparison to peripheral blood NK
cells. The ultimate goal is to use this flow cytometry-based method
as a tool to perform detailed immunological analyses of the role of
intrahepatic NK cells and other lymphocyte subsets in liver disease.
MATERIALS AND METHODS
REAGENTS, MEDIA, AND ANTIBODIES
The following reagents were used for cell isolation in this study:
Ficoll-Paque (GE Healthcare), collagenase type IV (Catalog num-
ber C5138, 700.5 U/mg solid collagen, Sigma-Aldrich), DNase
I grade II (Catalog number 10104159001, Roche), ACK lysing
buffer (Lonza), bovine serum albumin (BSA), and sodium azide
(both from Sigma-Aldrich). Buffer 1 was composed of Hank’s
balanced salt solution (HBSS) supplemented with 0.5 mg/ml col-
lagenase IV; 0.02 mg/ml DNase I; 2% fetal calf serum (FCS,
from Sigma-Aldrich); 25 mM HEPES; and 0.6% BSA, whereas
buffer 2 was composed of HBSS supplemented with 2% fetal calf
serum (FCS, from Sigma-Aldrich), 25 mM HEPES, 0.6% BSA, and
0.01 mg/ml DNase.
Cell culture media AIM-V, RPMI 1640, HBSS, phosphate
buffered saline (PBS),HEPES,penicillin/streptomycin,MEM non-
essential amino acids, essential amino acids, and sodium pyruvate
were from Gibco-BRL. l-Glutamine was from Biochrom AG.
Heat-inactivated pooled human AB serum was obtained from the
local blood transfusion center (Centre de transfusion sanguine,
HUG). Recombinant interleukin-2 (IL-2) was from Novartis, and
IL-12 from R&D Systems. Complete AIM-V medium refers to
AIM-V supplemented with 10% heat-inactivated pooled human
AB serum; 2 mM l-glutamine; 20 mM HEPES; 1 mM Na-pyruvate;
1% MEM non-essential amino acids; 2% essential amino acids; 1%
penicillin–streptomycin; 50 U/ml of IL-2; and 0.5 ng/ml of IL-12.
Anti-CD3 PE-Cy7 (clone SK7), anti-CD107a PE (clone H4A3),
and mouse-isotype IgG1 matched controls mAb (clone MOPC21)
were obtained from BD Biosciences. Anti-CD3 FITC (clone
UCHT1), anti-IFN-γ FITC (clone 4S.B3), anti-CD16 PE (clone
3G8), and anti-NKp46 PE (clone 9E2) were purchased from BioLe-
gend. Anti-CD56 APC (clone AF12-7H3, 8) was from Miltenyi
Biotec. BD Cytofix/Cytoperm and GolgiStop solutions were also
from BD Bioscience. Staining buffer consisted of PBS supple-
mented with 0.1% BSA and 0.02% sodium azide. All antibodies
were titrated appropriately in order to assure saturating condi-
tions for 0.1× 106 cells or less using 50µl incubation volumes.
Titrations started at the manufacturers’ suggestions. Final dilu-
tions varied from one antibody to another. The same amount of
antibody was used for 0.1× 106 to 2,500 cells.
SAMPLES
All liver tissue donors were treated at the University Hospital of
Geneva. The study protocol was approved by the institutional
review board, and written informed consent was obtained from
each subject. A total of 11 specimens were obtained from patients
suffering from chronic liver diseases at the time of percutaneous or
transjugular needle biopsy performed for diagnostic reasons. The
age of the patients ranged from 34 to 63 years (median 51 years),
and the male:female ratio was 5:6 (Table 1). Each sample was
sent for routine histological assessment and only the remaining
tissue was available for the isolation of IHL. In addition, five par-
tial liver resection specimens were obtained from patients during
surgery for hepatocellular carcinoma (n= 3), or echinococcosis
(n= 2). All tumor nodules, necrotic, and infected tissue fractions
were removed in order to obtain macroscopically unaffected liver
samples. The specimens were collected in RPMI 1640 medium
supplemented with 2 mM l-glutamine, 25 mM HEPES, 10% FCS,
penicillin (50 U/ml), and streptomycin (50µg/ml), and immedi-
ately transported to the laboratory for cell isolation. Peripheral
blood mononuclear cells (PBMC) were isolated from the blood
of healthy volunteers by standard Ficoll-Paque density gradient
centrifugation separation.
ISOLATION OF INTRAHEPATIC LYMPHOCYTES
An enzymatic digestion method was utilized for the isolation of
IHL modifying previously described protocols (Kawarabayashi
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Table 1 | Characteristics of liver biopsies specimens.
ID Diagnosis Gender Tissue collected
(mg)
*IHL
(×10−3)
†
IHL yield
(×10−3/mg)
‡
IHL viability
(%)
§NK cells
(%)
1 1 y post LT for polycystosis F 4 12 3.00 ND ND
2 Steatosis of undetermined origin F 22 140 6.36 ND ND
3 Steatohepatitis, hepatic siderosis F 11 60 5.45 ND ND
4 5 y post LT for chronic hepatitis C M 6 21 3.50 98.3 17.4
5 1 y post LT for sclerosing cholangitis M 9 40 4.44 73.6 5.9
6 Possible NASH, steatosis M 8 63 7.88 95.8 22.3
7 HCV cirrhosis M 10 97 9.70 94.4 7.0
8 Polyarteritis nodosa, HCV F 3 30 10.00 98.5 3.5
9 Chronic hepatitis B F 9.6 120 12.50 93.1 16.7
10 HCV cirrhosis M 11 130 11.82 93.0 4.5
11 Cirrhosis of undetermined origin F 6.5 40 6.35 95.3 8.1
Mean 9.1 68.5 7.36 92.7 10.7
F, female; HCV, hepatitis C virus; LT, liver transplantation; M, male; NAFLD, Non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; ND, not determinate.
*The number of IHL was calculated based on the absolute number of isolated cells from liver tissue after dissociation and the percentage of lymphocytes obtained
by flow cytometry FCS/SSC analysis.
†The yield of IHL was calculated using the total number of IHL per mg of liver tissue.
‡IHL viability was determined by dead cell exclusion using PI staining by flow cytometry.
§NK cell percentages were obtained by gating on the CD3−CD56+ quadrant after exclusion of PI positive cells in the lymphocyte gate as defined by size and granularity
in the FSC/SSC dot plot.
et al., 2000; Morsy et al., 2005). In brief, hepatic tissue was washed
thrice with HBSS containing 10% FCS to avoid blood contamina-
tion and to remove remaining intravascular lymphocytes. Samples
were cut into 1 mm× 1 mm pieces with scissors in warm HBSS;
then incubated for 30 min at 37˚C with frequent shaking in buffer
1. Not-dissociated tissue and cell clumps were removed by fil-
tration through a 30µm nylon cell strainer (Miltenyi Biotec).
To stop the enzymatic activity of the collagenase, the cells were
washed twice at 400 × g during 10 min in 4˚C cold HBSS contain-
ing 0.01 mg/ml DNase I. The cellular pellet was then resuspended
in ACK lysing buffer for 2 min at room temperature to remove red
blood cells, and then washed twice in AIM-V with 5% FCS. No
additional lymphocyte isolation procedure was utilized to avoid
any cell loss. Cells were used immediately for phenotypic flow
cytometry assays and overnight stimulation in complete AIM-V
media for functional analysis.
NK CELL PHENOTYPE ANALYSIS
Peripheral blood mononuclear cells or IHL were resuspended
in staining buffer, incubated for 30 min at 4˚C with saturating
concentrations of fluorescently labeled anti-CD3, -CD56, -CD16,
-NKp46 mAb, and respective isotype-matched control antibodies,
and analyzed by direct immunofluorescence on a FACS Calibur
(BD Biosciences). The number of acquired events depended on
the number of isolated cells and varied between 2,500 and 20,000.
Lymphocyte gating was performed based on the forward and side
scatter pattern; followed by dead cell exclusion using propidium
iodide (PI) in all experiments. NK cells were localized in the CD3-
negative and CD56-positive fraction (CD3−CD56+) (Figure 1A).
To control whether substantial numbers of viable NK cells were
excluded by the gating strategy described above, a back-gating con-
trol of all CD3−CD56+cells was used to trace them in the FCS/SSC
dot plot (Figure 1B). Results were analyzed by using FlowJo soft-
ware (Tree Star, Inc.) and presented as percentage of positive cells.
To compare the levels of surface expression, the geometric mean
fluorescence intensity ratios (MFIR) were calculated by dividing
the mean fluorescence intensity (MFI) of staining with the mAb of
interest with the MFI of the corresponding isotype control mAb.
FLOW CYTOMETRY-BASED NK CELL FUNCTIONAL ASSAY
Peripheral blood mononuclear cells or IHL were resuspended at
a concentration of 106/ml in complete AIM-V medium. Differ-
ent volumes of these suspensions were then seeded into 96-well
V- or U-bottom plates (Nunc) and cultured overnight at 37˚C in
5% CO2 and humidity in the presence of 50 U/ml of IL-2 and
0.5 ng/ml of IL-12. After careful removal of the culture media
avoiding the removal the IHL, an equal volume of K562 cells resus-
pended in complete AIM-V medium was added at an NK:K562
ratio of 1:1 unless stated otherwise in the text. To obtain the num-
ber of NK cells present in the functional assays and to adjust
the NK:K562 ratios to 1:1, viable PBMC or IHL were counted
after isolation, a sample stained for CD3/CD56 and analyzed by
FACS. The cell counts, the proportion of living cells in the lym-
phocyte gate, and the percentage of CD3−CD56+ NK cells were
used to calculate the absolute numbers. The appropriate amount
of K562 cells needed to obtain a NK to K562 ratio of 1:1 was
then added to the co-cultures. Anti-CD107a mAb (1.25µl/test)
or isotype control antibodies (0.25µl/test) were directly added to
the culture wells at this time and the culture plate was spun at
100 × g for 1 min and placed in the incubator. Following stimula-
tion with K562 cells for 1 h, GolgiStop (2µM) was added and the
cells were incubated for another 3 h at 37˚C in 5% CO2. PBMC
or IHL were then stained with anti-CD3 and anti-CD56 mAb for
30 min at 4˚C. Samples were then fixed, permeabilized according
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A
B
FIGURE 1 | Flow cytometry gating strategy for NK cells.
A representative example of the gating strategy used for the phenotypic
analysis of IHL is shown. (A) Lymphocytes were identified by their size
and granularity in the FSC/SSC dot plot (left), viability by excluding PI
positive cells (middle), and NK cells by gating on the CD3−CD56+
quadrant. The phenotype of NK cells was then further analyzed by a panel
of antibodies. (B) Back-gating control of all acquired CD3−CD56+ events in
the FSC/SSC dot plot.
to manufacturer’s instructions, and stained for intracellular IFN-γ
for 30 min at 4˚C. After washing, the expression of surface CD107a
and intracellular IFN-γ was analyzed in the CD3−CD56+ NK cell
fraction by four-color flow cytometry analysis.
STATISTICAL ANALYSIS
Values are expressed as mean or mean± standard error of the
mean (SEM) in the text and figures. The data were analyzed by a
one-way ANOVA F-test, followed by Tukey–Kramer post test for
multiple comparisons to evaluate each variable by pairs without
pre-assignment of a reference condition. A probability value of
p< 0.05 was considered to be statistically significant.
RESULTS
CELL YIELDS AND VIABILITY OF LIVER BIOPSY-DERIVED INTRAHEPATIC
LYMPHOCYTE
The different protocols published for the isolation of human IHL
from LB are associated with variable cell yields and viability (Pham
et al., 1994; Tran et al., 1997; Norris et al., 1998; Doherty et al., 1999;
Kawarabayashi et al., 2000; Apolinario et al., 2002; Meier et al.,
2005; Morsy et al., 2005; Tajiri et al., 2009). In the present work
IHL were isolated by a combination of physical and enzymatic
disruption of the liver tissue. Eleven LB specimens were analyzed
their mean weight being 9.1 mg (range 3–22 mg). Following the
liver dissociation, the viable isolated cells were counted by trypan
blue exclusion and analyzed by flow cytometry. The percentage of
IHL was obtained by gating on lymphocytes in the FCS/SSC dot
plots and the total number of IHL calculated. As shown in Table 1,
the mean viability of the IHL as measured by PI exclusion was
92.7% (range 73.6–98.5%), and the mean number of IHL isolated
from 1 mg of liver tissue 7,364 (range 3,000–12,500 IHL/mg).
EFFECT OF COLLAGENASE IV AND DNase I ON NK CELL VIABILITY AND
PHENOTYPE
As shown previously, enzymes such as collagenase IV and DNase
I used for the isolation of IHL, may decrease the viability and
expression of NK cell-surface markers such as CD56 (Curry et al.,
2000; Morsy et al., 2005; Uhrberg, 2005). We therefore addressed
the effect of these enzymes on the viability and surface expression
of CD3, CD16, CD56, and NKp46 on PBMC and IHL, respectively.
PBMC obtained from six healthy volunteers were incubated either
in AIM-V media alone, buffer 2 containing 0.01 mg/ml DNase I,
or in the presence of a combination of 0.5 mg/ml collagenase type
IV (buffer 1) during 10, 20, or 30 min at 37˚C. Moreover, hepatic
tissue from five different liver resection specimens was homoge-
nized and treated with a combination of collagenase type IV and
DNase I for the same periods of time at 37˚C. After RBC lysis and
washing, enzyme-treated PBMC and IHL were immediately used
for phenotypic analysis by flow cytometry.
Viability was tested by PI exclusion staining and was shown to
remain unchanged in both PBMC and IHL following incubation
with the enzymes for up to 30 min compared to control cells that
were exposed to media alone (Figure 2A). As to the expression
of NK cell-surface markers, the percentage of peripheral blood
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FIGURE 2 | Effect of collagenase IV and DNase I on NK cell viability
and phenotype. PBMC (open circles, n=6) or homogenized liver
tissue (filled circle, n=5) were exposed to buffer 1 (containing
collagenase IV and DNase I) for 10, 20, or 30 min at 37˚C. As a control,
cells were incubated in medium alone or buffer 2 (containing only
DNase I). (A) Cell viability was evaluated by PI staining. (B) Percentage
of CD56+ NK cells was determined by flow cytometry after gating on
living lymphocytes. (D) Percentage of CD16+ and (F) NKp46+ cells was
obtained by gating on CD3−CD56+ living lymphocytes. Mean
fluorescence intensity ratio (MFIR) for (C) CD56, (E) CD16, and (G)
NKp46 using the same gating strategy are also shown in the right
column. Data are shown as mean±SEM.
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CD56+cells was slightly decreased following 30 min of collagenase
digestion (12.08 versus 16.45%), however, the difference did not
reach statistical significance (F = 1.29, p= 0.3) (Figure 2B, open
circles). Importantly, the percentage of intrahepatic CD56+ NK
cells did not change when homogenized liver tissues were treated
with collagenase and DNase for different time periods (Figure 2B,
close circles). In addition, we confirmed that the percentage of
CD3+ (data not shown), CD16+ and NKp46+ PBMC and IHL was
unaffected after enzymatic treatment (Figures 2D,F, respectively).
In contrast, MFIR of CD56 expression on both PBMC (Figure 2C,
open circles, F = 5.16, p= 0.05) and IHL (Figure 2C, closed cir-
cles) was clearly reduced by enzymatic treatment, whereas CD3
(data not shown), CD16, and NKp46 expression levels did not
change (Figures 2E,G).
Independently of the effect of the enzymatic treatment, the
CD56, CD16, and NKp46 expression was shown to differ between
PBMC and IHL. The percentages and MFIR of CD56+cells were
higher in IHL than in PBMC, whereas the percentages and MFIR
of CD16+ cells were higher in PBMC. Finally, the percentages of
NKp46+ cells seemed to be equivalent in both, whereas the MFIR
was higher in IHL. In summary, the analysis of phenotype and cell
viability after enzymatic digestion treatment of PBMC and IHL
did not show any differences in the percentages of NK cells, but it
affected the level of CD56 surface expression.
NO EFFECT OF COLLAGENASE IV AND DNase I ON NK CELL FUNCTION
Limited information is available regarding the effect of enzymatic
digestion used for the isolation of IHL on subsequent testing of NK
cell functions, in particular degranulation and IFN-γ secretion.
To this end, PBMC and liver resection samples were treated with
0.5 mg/ml of collagenase type IV and 0.02 mg/ml of DNase I for 10,
20, and 30 min, respectively; stimulated with IL-2/IL-12 overnight,
co-incubated with K562 cells for additional 4 h, and analyzed by
flow cytometry. Despite large inter-individuals variations, intra-
cellular IFN-γ production and degranulation, as measured by
CD107a surface expression (Alter et al., 2004; Uhrberg, 2005),
of the NK cells present in PBMC did not differ between con-
trol and enzyme-treated samples, (Figures 3A,B; IFN-γ: F = 0.4,
p= 0.8; and CD107a: F = 0.5, p= 0.8). Furthermore, no func-
tional changes were observed in NK cells present in IHL iso-
lated from liver resection specimens using different collagenase
exposure times (Figures 3C,D). In general, intrahepatic NK cells
seemed to produce less IFN-γ than peripheral blood NK cells
although this difference did not reach statistical significance.
MINIMAL CELL NUMBERS NEEDED TO DETECT THE EXPRESSION OF
CD16 ON PBMC AND IHL
Analysis of intrahepatic human NK cells is technically challenging
given the very small number of IHL that can be obtained from nee-
dle LB. Therefore, the minimal number of cells necessary to assess
the phenotype and function of peripheral blood and liver NK cells
by flow cytometry was evaluated. As for the phenotype, CD16
was chosen because of its weak expression on IHL. First, we mea-
sured CD16 expression by multi-color flow cytometric analysis of
the CD3−CD56+ NK cell population using different numbers of
PBMC per tube, ranging from 200,000 down to 12,500 cells per
A B
C D
FIGURE 3 | Effect of collagenase IV and DNase I on NK cell function.
PBMC (n=5) or homogenized liver tissue (n=5) were exposed to
0.5 mg/ml collagenase IV (buffer 1) for 10 min (open triangles), 20 min (half
triangles), 30 min (filled triangles), medium (open circles), or buffer 2
(rings) containing 0.01 mg/ml DNase I for 30 min at 37˚C and incubated
overnight in the presence of IL-2/IL-12 (50 U/ml and 0.5 ng/ml,
respectively). Cells were then stimulated with K562 at a ratio of 1:1 for
another 4 h. Intracellular IFN-γ production and CD107a surface expression
on CD3−CD56+ NK cells were determined by antibody staining and flow
cytometry. (A) Pooled data (n=5) of the percentage of IFN-γ (left panel)
and CD107a (right panel) expression on peripheral blood NK cells
following enzyme exposure and activation and; (B) a representative
example of IFN-γ and CD107a expression on peripheral blood NK cells.
(C) Pooled data (n=5) of the percentage of IFN-γ (left panel) and CD107a
(right panel) expression on liver NK cells following enzyme exposure and
activation and; (D) a representative example of IFN-γ and CD107a
expression on liver NK cells. The mean values of five independent
experiments are shown.
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staining and acquiring 20,000 when possible or 12,500 events. The
results for the percentage of CD16+ NK cells (Figures 4A,C,E;
closed symbols) was the same, irrespective of whether 12,500
PBMC (95.94%,range 91.77–99.31%),or 200,000 PBMC (96.21%,
range 94.38–99.26%) were used in the labeling step (Figure 4A).
Next, we evaluated CD16 expression on liver resection-derived
IHL using different numbers, ranging from 100,000 down to 6,250
cells per tube and acquiring 20,000 events or less according to the
number of cells in the tube. The results for the percentage of
CD16+ NK cells using 100,000; 50,000; 25,000; 12,500; and 6,250
IHL per well, were 75.5, 79.7, 76.6, 75.4, and 78.1%, respectively.
Thus, there were no significant differences using as few as 6,500 cell
per tube for the analysis of CD16 expression as shown for five dif-
ferent donors (Figure 4C). At last, CD16 expression in LB-derived
IHL obtained from three donors was analyzed. The percentages
of CD16+ NK cells using 20,000; 10,000; 5,000–2,500 IHL per
tube and acquiring all possible events was 66.44, 64.8, 68.32, and
67.79%, respectively (Figure 4E). In conclusion, the percentage of
expression of CD16 on peripheral blood and intrahepatic NK cells
can be reliably determined by flow cytometry using as few as 2,500
cells per tube containing as few as 352 (range 103–486) NK cells
depending on the donor.
In order to further determine whether the total cell num-
ber used for the flow cytometry has an impact on the level of
A
C
E
B
D
F
FIGURE 4 | Low cell numbers do not affect the flow cytometry results of
CD16 expression on NK cell. PBMC were obtained from healthy volunteers;
IHL from liver resections and biopsies, respectively. Decreasing numbers of
cells, ranging between 200,000 and 12,500 for PBMC, 100,000 and 6,250 for
liver resection-derived IHL, and 20,000 and 2,500 for liver biopsy-derived IHL
were used for the analysis. The expression of CD16 on peripheral blood and
intrahepatic NK cells was determined by gating on CD3−CD56+ lymphocytes.
(A,B) Peripheral blood NK cells, n=3; (C,D) liver resection-derived IHL, n=5;
and (E,F) liver biopsy-derived IHL, n=3. Data are expressed as percentage
(A,C,E) and MFIR (B,D,F) of CD16+ NK cells.
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cell-surface marker expression, we assessed the MFIR of CD16
expression on peripheral blood and intrahepatic NK cells using
different cell numbers for the analysis (Figures 4B,D,F; open sym-
bols). The results for the MFIR of CD16 expression were identical
regardless of whether 1,250 or 200,000 cells were used for the cell
staining. This was true for both peripheral blood and intrahep-
atic NK cells, although large individual variations of CD16 MFIR
levels were noted among the donors. Peripheral blood NK cells
expressed CD16 with an MFIR ranging from 99.5 to 527.8 (mean
308) (Figure 4B), whereas the CD16 expression of intrahepatic
NK cells was 10 times lower with an MFIR ranging from 6.7 to
52.2 (mean 31.4) for liver resection-derived IHL (Figure 4D), and
from 11.0 to 83.8 (mean 41.3) for LB-derived IHL (Figure 4F).
Taken together, these results suggest that NK cell phenotype
analysis by flow cytometry using very low cell numbers give com-
parable results to standard cell numbers. In addition, we confirmed
that CD16 expression on liver NK cells is lower as compared to
peripheral blood NK cells.
OPTIMAL NK TO K562 RATIO FOR NK STIMULATION IN FUNCTIONAL
ASSAYS
Whereas the production of intracellular IFN-γ by NK cells can
be determined following overnight stimulation with IL-2/IL-12,
the evaluation of NK cell degranulation by CD107a cell-surface
expression, however, depends on additional stimulation with K562
cells using effector (PBMC) to target (K562) ratios of 10:1 or 5:1
(Alter et al., 2004; Meier et al., 2005; Aktas et al., 2009; Dessouki
et al., 2010). In the present study, NK to K562 ratios rather
than PBMC to K562 ratios were used to assess NK degranula-
tion and IFN-γ production. To this end, the percentage of NK
cells present in freshly isolated PBMC was measured by CD3 and
CD56 staining. According to the resulting percentage, the desired
NK:K562 ratio for the assays was adjusted. PBMC were incubated
overnight in complete AIM-V medium containing 50 U/ml of
IL-2 and 0.5 ng/ml of IL-12. K562 cells were added for another
4 h at NK:K562 ratios of 1:0.5, 1:1, 1:5, 1:10, and 1:20, respec-
tively. As shown in Figure 5A, the percentage of IFN-γ positive
CD3−CD56+NK cells remained unchanged using NK:K562 ratios
of 1:0.5 or 1:1 as compared to NK cells without K562 stimulation,
but decreased significantly when NK:K562 ratios of 1:10 or 1:20
were used (F = 9.137, p< 0.001). This result indicated that it is
important to determine the exact NK:K562 ratio in order to obtain
reliable results for intracellular IFN-γ determinations. As to NK
cell degranulation induced by K562 stimulation, the percentage
of CD107a expression on CD3−CD56+ NK cells following co-
incubation at different NK:K562 ratios, ranging from 1:0.5 up to
1:20, did not show any significant differences (F = 1.178, p= 0.3)
(Figure 5B). A representative dot plot for the detection of intra-
cellular IFN-γ and cell-surface CD107a expression is shown in
Figure 5C. Taken together, anNK:K562 ratio of 1:1 was found
A
C
B
FIGURE 5 | Impact of the NK:K562 ratio on NK cell functional analysis.
PBMC isolated from healthy volunteers were incubated overnight in the
presence of 50 U/ml IL-2 and 0.5 ng/ml IL-12, respectively. K562 cells were
added for another 4 h at NK:K562 ratios of either 1:20, 1:10, 1:5, 1:1, or
1:0.5, taking into account the percentage of NK cells present in each
PBMC isolation. (A) Percentage of IFN-γ positive CD3−CD56+ NK cells;
and (B) percentage of CD107a expression of CD3−CD56+ NK cells as
determined by flow cytometry following stimulation at different NK:K562
ratios. (C) A representative example of IFN-γ and CD107a expression of
activated peripheral blood NK cells upon stimulation with IL-2/IL-12
overnight and different NK:K562 ratios is shown. Data of seven
independent experiments are shown as mean and the p-values (*p<0.05;
***p<0.001) were calculated using one-way ANOVA test, followed by
Tukey–Kramer post-test.
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to be optimal for stimulating NK cells prior to the detection of
intracellular IFN-γ and cell-surface CD107a expression.
OPTIMAL CULTURE VOLUME AND PLATE TYPE FOR FUNCTIONAL
ANALYSIS OF LOW NUMBERS OF PERIPHERAL BLOOD AND
INTRAHEPATIC NK CELLS
To explore the best culture conditions requiring a minimal num-
ber of IHL to analyze NK phenotype and function, small culture
volumes and different plate shapes were tested. First, PBMC were
resuspended in complete AIM-V medium at a constant concentra-
tion of 106cells/ml and seeded in 96-well U- or V-bottom plates at
a total volume of 200, 100, 50, or 25µl. Following overnight incu-
bation flow cytometry analysis revealed a cell viability of near to
95% in all culture volumes. Moreover, there was no change of the
percentage of CD3−CD56+ NK cells in all cultures, using as few as
25µl of total volume (data not shown). Next, NK degranulation
and intracellular IFN-γ production were determined following
overnight culture using different volumes and different 96-well
plate types and subsequent stimulation with K562 cells for another
4 h at a 1:1 ratio. The production of IFN-γ significantly decreased
when U-bottom plates were used for the culture of small vol-
umes (F = 3.53, p= 0.04), as shown in Figure 6A (open circles).
More specifically, peripheral blood NK cells produced lower lev-
els of intracellular IFN-γ when the PBMC were seeded in 50 or
25µl of culture volume as compared to NK cells that were cul-
tured in a volume of 200µl (p= 0.03 and p= 0.01, respectively).
On the other hand, incubation of PBMC in V-bottom plates in
the same small culture volumes yielded higher values of IFN-γ
production. Although there was also a trend toward a decrease
of IFN-γ production using small volumes in V-bottom plates it
was not statistically significant (F = 0.844, p= 0.5), as shown in
Figure 6A (closed circles). As to the degranulation of NK cells,
the culture volume did not affect the expression of CD107a on
NK cells (Figure 6B), regardless of whether PBMC were seeded in
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200 l
IFN-
C
D
1
0
7
a
100 l 50 l 25 l
45.4
14.6
15.9
24.1
48.0
30.0
8.3
13.7
49.0
23.3
11.0
16.7
47.2
25.3
11.0
16.5
32.7
12.7
17.1
37.5
48.2
29.0
7.8
15.0
55.7
26.0
7.5
10.8
28.2
27.9
15.5
28.4
Culture volume ( l)
%
 I
F
N
-
p
o
s
N
K
 c
el
ls
Culture volume ( l)
%
 C
D
1
0
7
a
p
o
s
N
K
 c
el
ls
A
C
B
FIGURE 6 | Optimal culture volume and plate type for functional
analysis of low numbers of peripheral blood NK cells. PBMC isolated
from healthy volunteers were resuspended in 200, 100, 50, or 25µl of
complete AIM-V medium at a constant concentration of 106 cells/ml, and
seeded in either 96-well U-bottom (open symbols) or V-bottom (filled
symbols) plates overnight. K562 cells were added for another 4 h at a
ratio of 1:1 for final stimulation. (A) Percentages of IFN-γ positive
CD3−CD56+ NK cells (circles); and (B) percentages of CD107a
expression (triangles) of CD3−CD56+ NK cells as determined by flow
cytometry following culture in different culture volumes are shown.
(C) Representative dot plot examples of IFN-γ and CD107a expression of
NK cells cultured in different culture volumes as indicated, cultured either
in U-bottom plates (lower panel) or V-bottom plates (upper panel). Data of
five independent experiments are shown as mean and the p-values
(*p<0.05; **p<0.01) were calculated using one-way ANOVA test,
followed by Tukey–Kramer post-test.
www.frontiersin.org March 2013 | Volume 4 | Article 61 | 9
Li et al. Intrahepatic NK cell functional analysis
small volumes, or whether they were seeded in 96-well U- or V-
bottom plates (F = 1.5, p= 0.2 and F = 1.6, p= 0.2; respectively).
Representative experimental dot plots are shown in Figure 6C.
To complete the analysis, IHL isolated from liver resection
specimens were seeded in V-bottom plates in different culture vol-
umes and tested for NK cell function as describe above. There
were no significant differences between the various culture vol-
umes used, neither for intracellular IFN-γ production (F = 2.6,
p= 0.1), nor for CD107a expression (F = 1.2, p= 0.4), as shown in
Figures 7A–C. Finally, a paired analysis of NK cell function in
PBMC and IHL was performed acquiring a total number of each
25,000 PBMC and 38,000 LB-derived IHL total events obtained
from the same donor. The cells were resuspended in 50µl, seeded
in a V-bottom plate, and incubated in complete AIM-V overnight
before final stimulation with K562 cells for another 4 h at a 1:1
ratio. Whereas NK degranulation was found to be similar in
peripheral blood and intrahepatic NK cells, the level of intracel-
lular IFN-γ production was clearly higher in peripheral blood NK
cells as compared to intrahepatic NK cells, 31.8 versus 16.9% in
the representative experiment shown in Figure 7D.
Based on these results, we conclude that V-bottom plates are
more suitable than U-bottom plates for overnight cultures in the
presence of IL-2/IL-12 for the consequent determination of intra-
cellular IFN-γ production in NK cells, in particular when small
culture volumes and low cell numbers are used. By using V-bottom
plates and keeping the concentration at 106 cells/ml, it is possible
to obtain NK functional assays with reliable results starting with a
total volume of 25–50µl, containing as few as 25,000–50,000 IHL.
DISCUSSION
The techniques for the isolation of single cell suspensions of IHL
make use of mechanical and/or enzymatic dissociation of the
tissue which usually is obtained from surgical resections (Curry
et al., 2000; Morsy et al., 2005). Whereas mechanical methods have
yielded very low cell numbers with low viability, a combination of
gentle mechanical dissociation followed by digestion with collage-
nase type IV and DNase I resulted in higher yields of viable IHL
suitable for phenotypic characterization by flow cytometry (Curry
et al., 2000). In contrast to liver resection samples which depend
on surgical interventions, standard biopsies consist of approxi-
mately 1/50,000 of the total mass of a liver, and are considered to
be reasonably representative for diagnostic purposes (Bravo et al.,
2001; Cholongitas et al., 2006). However, due to the small size of
human needle LB specimen, the reported yields of IHL obtained
from LB are very limited, ranging from 1.0 to 8.0× 105 cells (Tran
et al., 1997; Apolinario et al., 2002; Meier et al., 2005; Tajiri et al.,
2009). This wide range in cell yields is most likely the result of
the different types and sizes of the needles used for the procedure,
the number of biopsy passes, as well as the isolation techniques.
In the present study, the IHL yield varied from 0.1 to 1.4× 105
cells (i.e., from 0.03 to 0.13× 105 IHL/mg of tissue), similar to the
results of Morsy et al. (2005) who reported a yield between 0.08
and 0.10× 105 IHL/mg of tissue. Other groups had lower total
yields (Tran et al., 1997; Apolinario et al., 2002; Meier et al., 2005;
Tajiri et al., 2009), however, details on the weight of the LB were
not given, and therefore it is not possible to compare the total cell
number/mg of tissue.
C
D
BA
FIGURE 7 | Optimal culture volume for functional analysis of low
numbers of intrahepatic lymphocytes. IHL isolated from five different
liver resection specimens were resuspended in 200, 100, 50, or 25µl
complete AIM-V medium, and seeded in 96-well V-bottom plates overnight.
K562 cells were added for another 4 h at a ratio of 1:1 for final stimulation.
(A) Percentages of IFN-γ positive CD3−CD56+ NK cells (filled circles, n=4);
and (B) percentages of CD107a expression (filled triangles, n=4) of
CD3−CD56+ NK cells as determined by flow cytometry following culture in
different culture volumes are shown. (C) Representative dot plot examples
of IFN-γ and CD107a expression of intrahepatic NK cells cultured in
different culture volumes as indicated are shown. (D) Representative dot
plot example of NK cell functional analysis using intrahepatic lymphocytes
isolated from a liver biopsy is depicted, in parallel to the same assay using
PBMC obtained from the same donor. IHL and PBMC were resuspended in
50µl complete AIM-V medium, and seeded in 96-well V-bottom plates
overnight. K562 cells were added for another 4 h at a ratio of 1:1 for final
stimulation. Dot plots depict the respective percentages of CD107a and
IFN-γ positive CD3−CD56+ NK cells.
NK CELL PHENOTYPE
Previous studies have found that DNase and collagenase prepara-
tions could affect the cell-surface expression of several markers,
such as CD2, CD3, CD4, CD8, CD56, αβ, and γδ TCR (Mulder
et al., 1994; Abuzakouk et al., 1996; Curry et al., 2000). However,
the expression of these surface markers was largely unchanged
when highly purified preparations containing less contaminating
proteolytic enzymes, shorter exposure times, and lower concentra-
tions were used (Norris et al., 1998; Morsy et al., 2005; Blom et al.,
2009). In agreement with the latter findings, our results demon-
strated that 30 min exposure to collagenase type IV (0.5 mg/ml)
and DNase I (0.02 mg/ml) did not induce any difference in IHL
viability, and the percentage of cells staining positively for CD56,
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NKp46, and CD16, respectively, stayed unaltered, as shown pre-
viously (Flynn et al., 1999). In contrast to the percentage and
in line with an earlier report (Mulder et al., 1994), the level of
CD56 surface expression, here reported as MFIR, was consid-
erable diminished after the enzymatic treatment. Most impor-
tantly, we showed that the intracellular IFN-γ production and
CD107a expression by NK cells was unaffected following 30 min
of enzymatic treatment. Thus, human IHL isolated by a combi-
nation of mechanical dissociation and enzymes digestion were
phenotypically and functionally representative.
Although flow cytometry cannot provide the information
about the exact histopathological hepatic tissue distribution of
IHL, it can determine the precise percentages of lymphocyte sub-
sets which extend the information obtained by other means. More-
over, multi-color flow cytometry of IHL can identify their pheno-
type including activation markers in more detail than immuno-
histology (Doherty and O’Farrelly, 2000; Tajiri et al., 2009). Due
to the very low IHL yields of LB specimens, a reliable method
using minimal numbers of IHL was developed to assess phenotypic
and functional characterization of intrahepatic NK cells. Previous
investigators had evaluated the NK cell phenotype by gating on
1,000–5,000 IHL (Pham et al., 1994; Tran et al., 1997). Our flow
cytometric analysis found that the CD16 expression on NK cells
was unchanged by analyzing as few as 5,000 or even 2,500 total
IHL (which correspond only to 644 and 352 counted NK cells,
respectively) as compared to 100,000 IHL. In conclusion, it is pos-
sible to reliably characterize the phenotype of LB-derived NK cells
by analyzing as few as 2,500–5,000 IHL per FACS tube. Using this
minimal numbers we confirmed the findings of previous studies
that intrahepatic NK cells express lower levels of CD16 and higher
levels of CD56 as compared to peripheral blood NK cells.
NK CELL FUNCTIONAL ASSAY
To date only a few reports on intrahepatic NK cell degranulation
and cytokine production have been published (Kawarabayashi
et al., 2000; Zhang et al., 2011; Kramer et al., 2012; Varchetta
et al., 2012). The small number of IHL available from LB and
the numbers needed for functional analyses prevent purification
protocols by cell sorting or magnetic isolation of intrahepatic
NK cells as routinely performed for peripheral blood NK cells.
In the present study we explored the minimal cell numbers and
culture volumes required for reliable functional analysis of intra-
hepatic NK cells. The mean percentages of CD107a+ intrahepatic
NK cells in response to stimulation with K562 target cells, and
intracellular IFN-γ+ intrahepatic NK cells following overnight
cytokine stimulation reached 60 and 40%, respectively. Our data
also demonstrate that intracellular IFN-γ staining was significantly
decreased when 50 or 25µl cell suspensions at a constant concen-
tration of 106 cells/ml were seeded in 96-well U-bottom plates.
In contrast, IFN-γ production remained unchanged when the
same volume was incubated in V-bottom plates. These findings
indicate that V-bottom plates are the optimal choice for small cul-
ture volumes to evaluate IFN-γ production by NK cells. This can
be simply explained by the closer contact of cells in V-bottom
plates as compared to U-bottom plates. Furthermore, stimulation
at an NK to K562 ratio of 1:1 was found to be optimal for testing
degranulation by CD107a surface expression. Intracellular IFN-γ
production was clearly lower when K562 cells were added at higher
ratios, indicating that K562 cells in excess influence the measure-
ments negatively. We can only hypothesize on the underlying
mechanism(s). The intracellular IFN-γ production of NK cells
seems to attain maximal levels following overnight stimulation
with IL-2/IL-12, whereas additional K562 stimulation for 4 h does
not lead to a further increase of the ongoing production. In con-
trast, K562 stimulation which is necessary to induce degranulation
may also induce IFN-γ secretion into the supernatant leading to
the observed decrease of intracellular IFN-γ in a K562 cell num-
ber dependent manner. The NK to K562 ratio of 1:1 is optimal
and in accordance with the original findings of Alter et al. (2004)
demonstrating that intracellular IFN-γ and CD107a expression
on NK cells can best be quantified simultaneously at PBMC to
K562 ratios of 10:1, with NK cells accounting for about 10% of
the PBMC. Our method differs only slightly from Zhang et al.
(2011) who used a final NK to K562 ratio of 2:1 studying IHL
that comprised nearly 20% of NK cells. They report between 10
and 40% of CD107a+ intrahepatic NK cells in response to K562
stimulation, higher values than found for peripheral blood NK
cells, whereas intracellular IFN-γ production was low, on aver-
age 5%, following cytokine and K562 stimulation. In contrast,
percentages of IFN-γ+ intrahepatic NK cells went up to 60% fol-
lowing PMA/ionomycin stimulation, with clearly lower values for
peripheral blood NK cells (5–40%). Kawarabayashi et al. (2000)
cultured IHL obtained from liver resections or PBMC on immobi-
lized anti-CD3 antibodies, IL-2,or a combination of IL-2 and IL-12
and measured their IFN-γ production by ELISA, and the anti-
tumor cytotoxicity by 51Cr-release assays. Compared to PBMC,
they report a higher IFN-γ production and cytotoxicity against
K562 target cells for IHL which decreased in samples obtained
from cirrhotic livers. Using IHL obtained by mechanical disrup-
tion and further homogenization on a cell strainer from LB, the
group of Nattermann (Eisenhardt et al., 2012; Kramer et al., 2012)
recently reported intrahepatic NK cell degranulation of 10–25%
in response to K562 stimulation, and inhibition of HCV replica-
tion in vitro. Finally, the group of Mondelli et al. (2010) reported
a comprehensive analysis of the phenotype and function of intra-
hepatic NK cells obtained by mechanical disruption and enzymatic
digestion (DNase 0.05 mg/ml; collagenase IV 0.5 mg/ml) in HCV
infected patients as compared to healthy controls (Varchetta et al.,
2012). Whereas the former study did not provide any details as
to the yields of IHL isolation and the number of cells used for
the functional assay, the latter gives information on the experi-
mental protocol in the supporting materials. At least 7× 105 cells
were plated in wells coated with the NKG2D ligand ULBP1 in
the presence of IL-2 and IL-12 for the functional degranulation
and cytokine secretion studies. The percentage of CD107a+ intra-
hepatic NK cells in response to K562 target cells was in average
35% for control and 25% for HCV infected patients, whereas our
results showed 50–60% CD107a+ intrahepatic NK cells isolated
from a heterogeneous population of patients. As to the produc-
tion of intracellular IFN-γ, 5–10% were shown by Varchetta et
al., whereas our stimulation method induced up to 50% IFN-γ+
intrahepatic NK cells. The percentage of intrahepatic NK cells
able to secrete IFN-γ was lower than for peripheral NK cells under
the same conditions while the degranulation of peripheral blood
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and intrahepatic NK cells after overnight cytokine stimulation
was comparable. Taken together, using an optimized method to
measure degranulation and intracellular IFN-γ production in low
numbers of intrahepatic NK cells isolated from standard LB we
confirm previous results on their CD107a expression but higher
values for IFN-γ production either due to the culture conditions,
which were optimized, or to the patient population studied.
In summary, characterization of intrahepatic NK cells in
humans is technically difficult, given the very small number of
lymphocytes that can be obtained from biopsies. In the present
study, we have developed a reliable and efficient four-color flow
cytometry method to evaluate the phenotype and function of
intrahepatic NK cells by using IHL isolated from LB. In view of
the recent advances in flow cytometry, this analysis can now be
extended to up to 10 color analyses, thus increasing the amount
of information collected from a LB. This novel method is espe-
cially suitable for analyzing needle biopsy samples, yielding only a
few milligrams of liver tissue, without the need of major surgical
interventions, since the phenotypic and functional analysis of
LB-derived NK cells required only 5,000 per tube and 50,000
cells per culture well, respectively. This minimal amount is suf-
ficient for reliable phenotypic and functional characterization
of intrahepatic NK cells and will allow studies of IHL in larger
cohorts which are critical for a comprehensive understanding
of intrahepatic immune responses in liver diseases such as viral
infections, autoimmune disease, and allograft rejection. Conse-
quently, the establishment of this novel protocol should become
highly valuable in attempts to elucidate the role of NK cells
and other lymphocyte subsets in the pathogenesis of such liver
diseases.
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